Navigation path

Horizon Prizes

Take a look at the Horizon Prizes web site to see which challenge you might take up ...

• Better use of Antibiotics • Breaking the optical transmission barriers
• Materials for clean air • Collaborative Spectrum Sharing • Food scanner

World Malaria Day: EU Research

According to the World Health Organisation, in 2010, an estimated 219 million malaria cases occurred globally and the disease killed about 660 000 people, mostly children under five years of age.

Since 2002, the EU has invested more than €209 million in 87 projects carrying out research into the disease and how to control it. In addition, through its partnership with sub-Saharan Africa (the EDCTP initiative), the EU is supporting 32 clinical trials into new treatments with some €50 million.

Thanks to the efforts of the EU and international community, as well as governments and health-care providers in endemic countries, malaria deaths have fallen by 25% since the year 2000.

Press release: EU research project develops new malaria test tool

More background information: Contribution of EU research to fight against Malaria

Here are two examples of successful, EU-funded malaria-related research projects:

Image of dead tiger mosquito

A big booster for vaccine development

An EU-funded project has accelerated the development of vaccines for diseases such as Lyme disease, malaria, tuberculosis, dengue, influenza, mumps, whooping cough, pneumonia, HIV, and two types of cancer. Their work could lead to new, more effective vaccines - potentially saving millions of people from disease.

Mosquito © Shutterstock

Malaria and the cloak of invisibility

An international team of scientists has discovered a key molecule that helps the malaria parasite evade the human body's immune system. Partially funded by the EU-backed EVIMALAR ('Towards the establishment of a permanent European virtual institute dedicated to malaria research') project and presented in the journal Cell Host & Microbe, the findings of this study could provide fresh insight into how the parasite that triggers disease can dodge the defences built by the immune system. EVIMALAR, meanwhile, is funded under the Health Theme of the EU's Seventh Framework Programme (FP7) to the tune of EUR 12 million.


For more information: